These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6332706)

  • 21. Racemization effects on melanocyte-stimulating hormones and related peptides.
    Bool AM; Gray GH; Hadley ME; Heward CB; Hruby VJ; Sawyer TK; Yang YC
    J Endocrinol; 1981 Jan; 88(1):57-65. PubMed ID: 6970245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropins.
    Marwan MM; Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Wilkes BC; Hruby VJ; Castrucci AM
    Mol Cell Endocrinol; 1985 Jul; 41(2-3):171-7. PubMed ID: 3926559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic lactam analogues of Ac-[Nle4]alpha-MSH4-11-NH2.
    Sugg EE; Castrucci AM; Hadley ME; van Binst G; Hruby VJ
    Biochemistry; 1988 Oct; 27(21):8181-8. PubMed ID: 2852955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationships of [Nle4, D-Phe7]alpha-MSH. Discovery of a tripeptidyl agonist exhibiting sustained bioactivity.
    Sawyer TK; Castrucci AM; Staples DJ; Affholter JA; De Vaux A; Hruby VJ; Hadley ME
    Ann N Y Acad Sci; 1993 May; 680():597-9. PubMed ID: 8390200
    [No Abstract]   [Full Text] [Related]  

  • 25. Calcium-dependent prolonged effects on melanophores of [4-norleucine, 7-D-phenylalanine]-alpha-melanotropin.
    Hadley ME; Anderson B; Heward CB; Sawyer TK; Hruby VJ
    Science; 1981 Aug; 213(4511):1025-7. PubMed ID: 6973820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipyretic activity of a potent alpha-MSH analog.
    Holdeman M; Lipton JM
    Peptides; 1985; 6(2):273-5. PubMed ID: 3875837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorine-18-labeled [Nle4,D-Phe7]-alpha-MSH, an alpha-melanocyte stimulating hormone analogue.
    Vaidyanathan G; Zalutsky MR
    Nucl Med Biol; 1997 Feb; 24(2):171-8. PubMed ID: 9089709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-melanocyte-stimulating hormone exhibits target cell selectivity in its capacity to affect interleukin 1-inducible responses in vivo and in vitro.
    Daynes RA; Robertson BA; Cho BH; Burnham DK; Newton R
    J Immunol; 1987 Jul; 139(1):103-9. PubMed ID: 3495595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and structure-function studies of melanocyte stimulating hormone analogues modified in the 2 and 4(7) positions: comparison of activities on frog skin melanophores and melanoma adenylate cyclase.
    Hruby VJ; Sawyer TK; Yang YC; Bregman MD; Hadley ME; Heward CB
    J Med Chem; 1980 Dec; 23(12):1432-7. PubMed ID: 7452698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological activity, binding, and metabolic fate of Ac-[Nle4, D-Phe7]alpha-MSH4-11NH2 with the F1 variant of B16 melanoma cells.
    Panasci LC; McQuillan A; Kaufman M
    J Cell Physiol; 1987 Jul; 132(1):97-103. PubMed ID: 3110178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanotropin bioassays: in vitro and in vivo comparisons.
    Castrucci AM; Hadley ME; Hruby VJ
    Gen Comp Endocrinol; 1984 Jul; 55(1):104-11. PubMed ID: 6611282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, biology, and conformations of bicyclic alpha-melanotropin analogues.
    Haskell-Luevano C; Shenderovich MD; Sharma SD; Nikiforovich GV; Hadley ME; Hruby VJ
    J Med Chem; 1995 May; 38(10):1736-50. PubMed ID: 7752197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The melanocyte-stimulating hormone (MSH) receptor in M2R mouse melanoma tumours: solubilization and properties of the receptor-MSH complex and its covalently crosslinked conjugate.
    Shafir I; Schmidt-Sole J; Shai E; Salomon Y
    Melanoma Res; 1993 Jun; 3(3):157-68. PubMed ID: 8400853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term and residual melanotropin-stimulated tyrosinase activity in S91 melanoma cells is density dependent.
    Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Bregman MD; Hruby VJ; Meyskens FL
    In Vitro Cell Dev Biol; 1986 Feb; 22(2):75-81. PubMed ID: 3081484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic melanotropins. Part VII: Modified ring structures--synthesis and biological activity.
    Lebl M; Cody WL; Wilkes BC; Hruby VJ; Castrucci AM; Hadley ME
    Int J Pept Protein Res; 1984 Nov; 24(5):472-9. PubMed ID: 6335135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of conformational isomerism in alpha-melanocyte stimulating hormone by design of cyclic analogues.
    Nikiforovich GV; Sharma SD; Hadley ME; Hruby VJ
    Biopolymers; 1998 Sep; 46(3):155-67. PubMed ID: 9699465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and conformational modifications of alpha-MSH/ACTH4-10 provide melanotropin analogues with highly potent behavioral activities.
    Hirsch MD; O'Donohue TL; Wilson R; Sawyer TK; Hruby VJ; Hadley ME; Cody WL; Knittel JJ; Crawley JN
    Peptides; 1984; 5(6):1197-201. PubMed ID: 6099564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo.
    Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
    Int J Cancer; 1994 Sep; 58(5):749-55. PubMed ID: 8077062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible bioactive conformations of alpha-melanotropin.
    Nikiforovich GV; Rozenblit SA; Shenderovich MD; Chipens GI
    FEBS Lett; 1984 May; 170(2):315-20. PubMed ID: 6723968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of an alpha-melanocyte stimulating hormone (alpha-MSH) radioimmunoassay to the detection of the superpotent analog, [Nle4,D-Phe7]-alpha-MSH.
    Kreutzfeld KL; Bagnara JT
    Pigment Cell Res; 1989; 2(1):65-9. PubMed ID: 2541421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.